News

Merck price target lowered to $82 from $89 at BMO Capital
BMO Capital analyst Evan Seigerman lowered the firm’s price target on Merck (MRK) to $82 from $89 and keeps a Market Perform rating on the ...
Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion
Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...
Wells Fargo Reaffirms Their Hold Rating on Merck & Company (MRK)
In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Hold rating on Merck & Company (MRK – Research Report), with a ...